Kevin J. Cameron

Insider Reports History

Entity
Individual
Location
C/O Keryx Biopharmaceuticals, Inc., 750 Lexington Avenue, New York, New York
Signature
/s/ Vik Varma, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin J. Cameron:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CUTERA INC Director Stock Option (Right to Buy) 25.3 K May 19, 2023 Direct

Insider Reports Filed by Kevin J. Cameron

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CUTR CUTERA INC May 19, 2023 1 $0 4 May 30, 2023 Director
CUTR CUTERA INC May 19, 2023 0 $0 3 May 30, 2023 Director